lamivudine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachmeyer, C; Benchaa, B; Blum, L; Danne, O; Gruat, N; Stelianides, S | 1 |
1 other study(ies) available for lamivudine and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; Humans; Immunocompromised Host; Lamivudine; Lung Diseases; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2002 |